At 48 hr post‐stroke, BML‐111 reduced levels of pro‐inflammatory cytokines TNF‐α and IFNγ compared to levels in the vehicle‐treated rats (p = .0638, p < .01, respectively; Figure 4a,b). The gene discussed is TNF; the disease is Stroke.